kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports Targeting KRAS-mutant stomach/colorectal tumors by
Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



